Induction of autophagy and autophagy-dependent apoptosis in diffuse large B-cell lymphoma by a new antimalarial artemisinin derivative, SM1044

Author:

Cheng Chunyan1ORCID,Wang Tao1,Song Zhiqun2,Peng Lijun1,Gao Mengqing1,Hermine Olivier3,Rousseaux Sophie4,Khochbin Saadi4,Mi Jian-Qing1,Wang Jin1ORCID

Affiliation:

1. State Key Laboratory for Medical Genomics; Department of Hematology; Shanghai Institute of Hematology; Collaborative Innovation Center of Systems Biomedicine; Pôle Sino-Français des Sciences du Vivant et Genomique; Rui Jin Hospital; Shanghai Jiao Tong University School of Medicine; Shanghai China

2. Department of Blood Transfusion; the First Affiliated Hospital of Nanjing Medical University; Nanjing Jiangsu China

3. Service d'Hématologie Adultes; Hôpital Necker-Enfants Malades; Assistance Publique-Hôpitaux de Paris; Université Paris Descartes; Paris France

4. CNRS UMR 5309/INSERM U1209/Université Grenoble-Alpes/Institute for Advanced Biosciences; La Tronche France

Funder

Agence Nationale de la Recherche

Science and Technology Commission of Shanghai Municipality

Institut National Du Cancer

Fondation ARC pour la Recherche sur le Cancer

National Natural Science Foundation of China

Institut National de la Santé et de la Recherche Médicale

Shanghai Leading Talent Projects

ITMO Cancer

Fondation pour la Recherche Médicale

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Reference49 articles.

1. Guidelines for the management of diffuse large B-cell lymphoma;Chaganti;Br. J. Haematol.,2016

2. Relapsed/refractory diffuse large B-cell lymphoma;Friedberg;Hematol. Am. Soc. Hematol. Edu. Program,2011

3. Biological prognostic markers in diffuse large B-cell lymphoma;Perry;Cancer Control,2012

4. Prognostic and biological significance of Survivin expression in patients with diffuse large B-cell lymphoma treated with rituximab-CHOP therapy;Liu;Modern Pathol.,2015

5. Inhibition of apoptosis by Survivin predicts shorter survival rates in colorectal cancer;Kawasaki;Can. Res.,1998

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3